Skip to content

UROPLASTY INC: 10-Q filed 2012-10-25

What UROPLASTY INC reported in its quarterly report filed 2012-10-25 (fiscal Q2 2012): 37 published measures, 99 facts as tagged in accession 0001140361-12-044664.

This filing

Form
10-Q (quarterly report)
Filed
2012-10-25
Fiscal period
fiscal Q2 2012
Accession
0001140361-12-044664 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All UROPLASTY INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-3021,051,228USD
At 2012-03-3122,290,813USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-303,013,618USD
At 2012-03-313,056,058USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-3018,037,610USD
At 2012-03-3119,234,755USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-304,611,542USD
At 2012-03-314,653,226USD
At 2011-09-309,538,350USD
At 2011-03-316,063,573USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-639,526USD92
2012-04-01 to 2012-09-30-1,658,881USD183
2011-07-01 to 2011-09-30-1,278,487USD92
2011-04-01 to 2011-09-30-2,609,794USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-04-01 to 2012-09-30-891,673USD183
2011-04-01 to 2011-09-30-2,281,152USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-04-01 to 2012-09-3093,981USD183
2011-04-01 to 2011-09-30106,325USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-07-01 to 2012-09-305,710,000USD92
2012-04-01 to 2012-09-3011,287,000USD183
2011-07-01 to 2011-09-304,968,000USD92
2011-04-01 to 2011-09-309,621,000USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-04-01 to 2012-09-30150,000USD183
2011-04-01 to 2011-09-30207,050USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-04-01 to 2012-09-30710,569USD183
2011-04-01 to 2011-09-305,564,703USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-30-37,174,716USD
At 2012-03-31-35,515,835USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-07-01 to 2012-09-3014,637USD92
2012-04-01 to 2012-09-3023,104USD183
2011-07-01 to 2011-09-308,485USD92
2011-04-01 to 2011-09-3022,416USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-301,087,182USD
At 2012-03-311,171,979USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-04-01 to 2012-09-30353,060USD183
2011-04-01 to 2011-09-30288,754USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-641,614USD92
2012-04-01 to 2012-09-30-1,655,409USD183
2011-07-01 to 2011-09-30-1,275,074USD92
2011-04-01 to 2011-09-30-2,615,592USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-3019,087,560USD
At 2012-03-3115,620,942USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-300USD92
2012-04-01 to 2012-09-300USD183
2011-07-01 to 2011-09-3057USD92
2011-04-01 to 2011-09-3057USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-302,565,468USD
At 2012-03-312,539,619USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-30614,919USD
At 2012-03-31593,585USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-09-30519,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-09-302,577,134USD
At 2012-03-312,704,434USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-305,576,491USD92
2012-04-01 to 2012-09-3011,411,822USD183
2011-07-01 to 2011-09-305,483,359USD92
2011-04-01 to 2011-09-3010,767,434USD183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-09-30869,554USD
At 2012-03-31698,742USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-304,934,877USD92
2012-04-01 to 2012-09-309,756,413USD183
2011-07-01 to 2011-09-304,208,285USD92
2011-04-01 to 2011-09-308,151,842USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-30598,933USD92
2012-04-01 to 2012-09-301,161,974USD183
2011-07-01 to 2011-09-30456,871USD92
2011-04-01 to 2011-09-30912,631USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3020,989,982shares
At 2012-03-3120,808,532shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-09-30-407,112USD
At 2012-03-31-364,165USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-09-30519,030USD
At 2012-03-31945,880USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-607,235USD92
2012-04-01 to 2012-09-30-1,701,828USD183
2011-07-01 to 2011-09-30-1,357,327USD92
2011-04-01 to 2011-09-30-2,652,533USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,027,835USD92
2012-04-01 to 2012-09-302,119,681USD183
2011-07-01 to 2011-09-30942,557USD92
2011-04-01 to 2011-09-301,964,415USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-04-01 to 2012-09-30576,665USD183
2011-04-01 to 2011-09-30552,275USD183

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-07-01 to 2012-09-30215,681USD92
2012-04-01 to 2012-09-30431,290USD183
2011-07-01 to 2011-09-30214,056USD92
2011-04-01 to 2011-09-30426,371USD183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-3016,725USD92
2012-04-01 to 2012-09-3019,632USD183
2011-07-01 to 2011-09-305,072USD92
2011-04-01 to 2011-09-3028,214USD183

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-04-01 to 2012-09-302,860USD183
2011-04-01 to 2011-09-30-3,040USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-09-30-100,537USD183
2011-04-01 to 2011-09-30196,435USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-09-30175,833USD183
2011-04-01 to 2011-09-3065,281USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-09-3026,516USD183
2011-04-01 to 2011-09-30-27,130USD183

Inspect the source

Entity
UROPLASTY INC / CIK 0000890846
Captured
SEC response SHA-256
19849e6278f98a98bf135df02adb6fd292e8724ef3ceac26af63b4fe931981a9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000890846.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))